Charles Schwab’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $21.4M | Sell |
|
|||||
|
2024
Q1 | $28.1M | Buy |
|
|||||
|
2023
Q4 | $27.5M | Buy |
|
|||||
|
2023
Q3 | $11.3M | Buy |
|
|||||
|
2023
Q2 | $16M | Buy |
|
|||||
|
2023
Q1 | $11.9M | Buy |
|
|||||
|
2022
Q4 | $15.3M | Buy |
|
|||||
|
2022
Q3 | $13.2M | Buy |
|
|||||
|
2022
Q2 | $10.5M | Buy |
|
|||||
|
2022
Q1 | $13M | Buy |
|
|||||
|
2021
Q4 | $11.8M | Buy |
|
|||||
|
2021
Q3 | $10.4M | Buy |
|
|||||
|
2021
Q2 | $6.44M | Buy |
|
|||||
|
2021
Q1 | $2.36M | Buy |
|
|||||
|
2020
Q4 | $2.77M | Buy |
|